Benjamin L. Judson, MD, MBA

• Aarti Bhatia
• Amit Mahajan
• Andrea Barbieri
• Anita Huttner
• Barbara Burtness
• Bonnie Gould Rothberg
• Bruno Cardoso
• Courtney Elizabeth Gibson
• Daniel Boffa
• Daniel Jacobs
• Dimitra P. Vageli
• Dirk C Johnson
• Eugenia Buta
• Eugenia M. Vining
• Gary Bellinger
• Hari Deshpande
• Harriet Kluger
• Henry S. Park
• John Morton
• Kanat Yalcin
• Kelly Olino
• Kerin Adelson
• Ketu Mishra-Gorur
• Kevin Billingsley
• Kimberly Davis
• Manju Prasad
• Melissa Rasar Young
• Michael Cecchini
• Michael Girardi
• Murat Gunel
• Nicholas Blondin
• Nita Ahuja
• Patricia Peter
• R Peter Manes
• Robert Fulbright
• Roy S. Herbst
• Sacit Bulent Omay
• Salman Punekar
• Sam Payabvash
• Saral Mehra
• Tanyeri Barak
• Theresa Ermer
• Yi An
• Zeynep Erson Omay
• Zuoheng Anita Wang

Neoplasms; Otorhinolaryngologic Diseases

• Abstract PO-047: A novel saliva miRNA panel of promising diagnostic biomarkers for oral cancer: The association of miR-21 with smoking historyVageli D, Doukas P, Judson B. Abstract PO-047: A novel saliva miRNA panel of promising diagnostic biomarkers for oral cancer: The association of miR-21 with smoking history. Clinical Cancer Research 2023, 29: po-047-po-047. DOI: 10.1158/1557-3265.aacrahns23-po-047.
• A Novel Saliva and Serum miRNA Panel as a Potential Useful Index for Oral Cancer and the Association of miR-21 with Smoking History: a Pilot Study.Vageli D, Doukas P, Shah R, Boyi T, Liu C, Judson B. A Novel Saliva and Serum miRNA Panel as a Potential Useful Index for Oral Cancer and the Association of miR-21 with Smoking History: a Pilot Study. Cancer Prevention Research 2023, 16: 653-659. PMID: 37683274, DOI: 10.1158/1940-6207.capr-23-0219.
• Association of Age and Frailty With 30‐Day Outcomes Among Patients Undergoing Oral Cavity Cancer SurgeryBoyi T, Williams L, Kafle S, Roche A, Judson B. Association of Age and Frailty With 30‐Day Outcomes Among Patients Undergoing Oral Cavity Cancer Surgery. Otolaryngology 2023, 169: 1523-1532. PMID: 37595108, DOI: 10.1002/ohn.476.
• Prognostic value of absolute lymphocyte count in oral cavity squamous cell carcinomaShah R, Liu C, Shah H, Judson B. Prognostic value of absolute lymphocyte count in oral cavity squamous cell carcinoma. Laryngoscope Investigative Otolaryngology 2023, 8: 870-875. PMID: 37621277, PMCID: PMC10446262, DOI: 10.1002/lio2.1094.
• Improving Post-procedure Outcomes With Clinical Care Pathway for Enteral AccessMiller S, Abou-Azar S, Owusu K, Judson B, Rhodes D, Morton J. Improving Post-procedure Outcomes With Clinical Care Pathway for Enteral Access. The American Surgeon 2023, 89: 6362-6365. PMID: 37203186, DOI: 10.1177/00031348231177914.
• Trends in Residency Applicant Volume in Otolaryngology-Head and Neck Surgery and Peer SpecialtiesBourdillon AT, Salehi PP, Wride M, Salehi P, Torabi S, Heiser A, Shah HP, Azizzadeh B, Judson B, Lee YH. Trends in Residency Applicant Volume in Otolaryngology-Head and Neck Surgery and Peer Specialties. Annals Of Otology Rhinology & Laryngology 2022, 132: 895-904. PMID: 36031814, DOI: 10.1177/00034894221120303.
• The Effect of Tobacco Smoke N-Nitrosamines, NNK and NDEA, and Nicotine, on DNA Mismatch Repair Mechanism and miRNA Markers, in Hypopharyngeal Squamous Cell Carcinoma: An In Vivo Model and Clinical EvidenceDoukas SG, Vageli DP, Doukas PG, Nikitovic D, Tsatsakis A, Judson BL. The Effect of Tobacco Smoke N-Nitrosamines, NNK and NDEA, and Nicotine, on DNA Mismatch Repair Mechanism and miRNA Markers, in Hypopharyngeal Squamous Cell Carcinoma: An In Vivo Model and Clinical Evidence. Current Oncology 2022, 29: 5531-5549. PMID: 36005175, PMCID: PMC9406897, DOI: 10.3390/curroncol29080437.
• The Role of PARP‐1 and NF‐κB in Bile‐Induced DNA Damage and Oncogenic Profile in Hypopharyngeal CellsDoukas PG, Vageli DP, Judson BL. The Role of PARP‐1 and NF‐κB in Bile‐Induced DNA Damage and Oncogenic Profile in Hypopharyngeal Cells. The Laryngoscope 2022, 133: 1146-1155. PMID: 35791892, DOI: 10.1002/lary.30284.
• PET/CT-Radiomics zuzüglich zum UICC-Staging könnten die Prognostik des Progressionsfreien Überlebens (PFS) und Gesamtüberlebens (OS) beim Oropharyngealen Plattenepithelkarzinom (OPSCC) verbessernHaider S, Sharaf K, Zeevi T, Mahajan A, Forghani R, Judson B, Kann B, Burtness B, Reichel C, Baumeister P, Payabvash S. PET/CT-Radiomics zuzüglich zum UICC-Staging könnten die Prognostik des Progressionsfreien Überlebens (PFS) und Gesamtüberlebens (OS) beim Oropharyngealen Plattenepithelkarzinom (OPSCC) verbessern. Laryngo-Rhino-Otologie 2022, 101: s13-s13. DOI: 10.1055/s-0042-1747116.
• PET/CT radiomics potentially improves progression-free survival (PFS) and overall survival (OS) prognostication beyond UICC TNM staging in oropharyngeal squamous cell carcinoma (OPSCC) patientsHaider S, Sharaf K, Zeevi T, Mahajan A, Forghani R, Judson B, Kann B, Burtness B, Reichel C, Baumeister P, Payabvash S. PET/CT radiomics potentially improves progression-free survival (PFS) and overall survival (OS) prognostication beyond UICC TNM staging in oropharyngeal squamous cell carcinoma (OPSCC) patients. Laryngo-Rhino-Otologie 2022, 101: s184-s184. DOI: 10.1055/s-0042-1746471.
• Noxious Combination of Tobacco Smoke Nitrosamines with Bile, Deoxycholic Acid, Promotes Hypopharyngeal Squamous Cell Carcinoma, via NFκB, In Vivo.Vageli DP, Doukas PG, Doukas SG, Tsatsakis A, Judson BL. Noxious Combination of Tobacco Smoke Nitrosamines with Bile, Deoxycholic Acid, Promotes Hypopharyngeal Squamous Cell Carcinoma, via NFκB, In Vivo. Cancer Prevention Research 2022, 15: 297-308. PMID: 35502554, DOI: 10.1158/1940-6207.capr-21-0529.
• TRAF7 Mutated Subgroups Differ in Sphenoid Wing Meningiomas with HyperostosisJin L, Vetsa S, Vasandani S, Nadar A, Youngblood M, Gupte T, Barak T, Yalcin K, Aguilera S, Mishra-Gorur K, Blondin N, Gorelick E, Omay S, Pointdujour-Lim R, Judson B, Alperovich M, Aboian M, Marianayagam N, McGuone D, Gunel M, Erson-Omay Z, Fulbright R, Moliterno J. TRAF7 Mutated Subgroups Differ in Sphenoid Wing Meningiomas with Hyperostosis. Journal Of Neurological Surgery Part B Skull Base 2022, 83: s1-s270. DOI: 10.1055/s-0042-1743640.
• Resident Burnout and Well‐being in Otolaryngology and Other Surgical Specialties: Strategies for ChangeShah HP, Salehi PP, Ihnat J, Kim DD, Salehi P, Judson BL, Azizzadeh B, Lee YH. Resident Burnout and Well‐being in Otolaryngology and Other Surgical Specialties: Strategies for Change. Otolaryngology 2022, 168: 165-179. PMID: 35133919, DOI: 10.1177/01945998221076482.
• Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastomaLechner M, Takahashi Y, Turri-Zanoni M, Liu J, Counsell N, Hermsen M, Kaur RP, Zhao T, Ramanathan M, Schartinger VH, Emanuel O, Helman S, Varghese J, Dudas J, Riechelmann H, Sprung S, Haybaeck J, Howard D, Engel NW, Stewart S, Brooks L, Pickles JC, Jacques TS, Fenton TR, Williams L, Vaz FM, O'Flynn P, Stimpson P, Wang S, Hannan SA, Unadkat S, Hughes J, Dwivedi R, Forde CT, Randhawa P, Gane S, Joseph J, Andrews PJ, Royle G, Franchi A, Maragliano R, Battocchio S, Bewicke-Copley H, Pipinikas C, Webster A, Thirlwell C, Ho D, Teschendorff A, Zhu T, Steele CD, Pillay N, Vanhaesebroeck B, Mohyeldin A, Fernandez-Miranda J, Park KW, Le QT, West RB, Saade R, Manes RP, Omay SB, Vining EM, Judson BL, Yarbrough WG, Sansovini M, Silvia N, Grassi I, Bongiovanni A, Capper D, Schüller U, Thavaraj S, Sandison A, Surda P, Hopkins C, Ferrari M, Mattavelli D, Rampinelli V, Facchetti F, Nicolai P, Bossi P, Henriquez OA, Magliocca K, Solares CA, Wise SK, Llorente JL, Patel ZM, Nayak JV, Hwang PH, Lacy PD, Woods R, O'Neill JP, Jay A, Carnell D, Forster MD, Ishii M, London NR, Bell DM, Gallia GL, Castelnuovo P, Severi S, Lund VJ, Hanna EY. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. European Journal Of Cancer 2021, 162: 221-236. PMID: 34980502, PMCID: PMC9554673, DOI: 10.1016/j.ejca.2021.09.046.
• Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival – A National studyCohen O, Brauer PR, Judson BL, Burtness BA, Earles J, Mehra S. Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival – A National study. Oral Oncology 2021, 125: 105694. PMID: 34971883, DOI: 10.1016/j.oraloncology.2021.105694.
• Targeting STAT3 prevents bile reflux‐induced oncogenic molecular events linked to hypopharyngeal carcinogenesisVageli DP, Doukas PG, Siametis A, Judson BL. Targeting STAT3 prevents bile reflux‐induced oncogenic molecular events linked to hypopharyngeal carcinogenesis. Journal Of Cellular And Molecular Medicine 2021, 26: 75-87. PMID: 34850540, PMCID: PMC8742186, DOI: 10.1111/jcmm.17011.
• Major Salivary Gland Cancer With Distant Metastasis Upon Presentation: Patterns, Outcomes, and Imaging ImplicationsBenchetrit L, Mehra S, Mahajan A, Rahmati RW, Judson BL, Edwards HA. Major Salivary Gland Cancer With Distant Metastasis Upon Presentation: Patterns, Outcomes, and Imaging Implications. Otolaryngology 2021, 167: 305-315. PMID: 34784258, DOI: 10.1177/01945998211058354.
• NIMG-64. TYPE OF BONY INVOLVEMENT PREDICTS GENOMIC SUBGROUP IN SPHENOID WING MENINGIOMASJin L, Youngblood M, Gupte T, Vetsa S, Nadar A, Barak T, Yalcin K, Aguilera S, Mishra-Gorur K, Blondin N, Omay S, Pointdujour-Lim R, Judson B, Alperovich M, Aboian M, McGuone D, Gunel M, Erson-Omay Z, Fulbright R, Moliterno J. NIMG-64. TYPE OF BONY INVOLVEMENT PREDICTS GENOMIC SUBGROUP IN SPHENOID WING MENINGIOMAS. Neuro-Oncology 2021, 23: vi144-vi144. PMCID: PMC8598770, DOI: 10.1093/neuonc/noab196.562.
• Bile reflux and hypopharyngeal cancerVageli DP, Doukas SG, Doukas PG, Judson BL. Bile reflux and hypopharyngeal cancer. Oncology Reports 2021, 46: 244. PMID: 34558652, PMCID: PMC8485019, DOI: 10.3892/or.2021.8195.
• Assessing Human Papillomavirus Awareness and the Role of Oropharyngeal Squamous Cell Carcinoma Education on Improving Intention to VaccinateTorabi SJ, Su‐Velez B, Kasle DA, Yarbrough WG, St. John M, Judson BL. Assessing Human Papillomavirus Awareness and the Role of Oropharyngeal Squamous Cell Carcinoma Education on Improving Intention to Vaccinate. The Laryngoscope 2021, 132: 528-537. PMID: 34383306, DOI: 10.1002/lary.29805.
• Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomasJin L, Youngblood MW, Gupte TP, Vetsa S, Nadar A, Barak T, Yalcin K, Aguilera SM, Mishra-Gorur K, Blondin NA, Gorelick E, Omay SB, Pointdujour-Lim R, Judson BL, Alperovich M, Aboian MS, McGuone D, Gunel M, Erson-Omay Z, Fulbright RK, Moliterno J. Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas. Journal Of Neuro-Oncology 2021, 154: 237-246. PMID: 34350560, DOI: 10.1007/s11060-021-03819-2.
• Devising novel imaging biomarkers for Human Papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC): applying radiomics and machine learning algorithmsHaider S, Mahajan A, Zeevi T, Forghani R, Kann B, Judson B, Burtness B, Sharaf K, Reichel C, Baumeister P, Payabvash S. Devising novel imaging biomarkers for Human Papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC): applying radiomics and machine learning algorithms. Laryngo-Rhino-Otologie 2021, 100: s99. DOI: 10.1055/s-0041-1727889.
• Entwicklung bildbasierter Radiomics-Biomarker für den Humanen Papillomavirus (HPV)-Status beim oropharyngealen Plattenepithelkarzinom (OPSCC) mittels Machine-Learning-AlgorithmenHaider S, Mahajan A, Zeevi T, Forghani R, Kann B, Judson B, Burtness B, Sharaf K, Reichel C, Baumeister P, Payabvash S. Entwicklung bildbasierter Radiomics-Biomarker für den Humanen Papillomavirus (HPV)-Status beim oropharyngealen Plattenepithelkarzinom (OPSCC) mittels Machine-Learning-Algorithmen. Laryngo-Rhino-Otologie 2021, 100: s65. DOI: 10.1055/s-0041-1727786.
• Pepsin Promotes Activation of Epidermal Growth Factor Receptor and Downstream Oncogenic Pathways, at Slightly Acidic and Neutral pH, in Exposed Hypopharyngeal CellsDoukas PG, Vageli DP, Sasaki CT, Judson BL. Pepsin Promotes Activation of Epidermal Growth Factor Receptor and Downstream Oncogenic Pathways, at Slightly Acidic and Neutral pH, in Exposed Hypopharyngeal Cells. International Journal Of Molecular Sciences 2021, 22: 4275. PMID: 33924087, PMCID: PMC8074291, DOI: 10.3390/ijms22084275.
• A 2020 Update on Public Awareness of Head and Neck CancersTorabi SJ, Kasle DA, Su-Velez B, Mehra S, Day TA, Yarbrough WG, St. John M, Judson BL. A 2020 Update on Public Awareness of Head and Neck Cancers. Otolaryngology 2021, 166: 305-312. PMID: 33845657, DOI: 10.1177/01945998211006932.
• Anesthesia screen use may impact operating room communication practices in otolaryngologyBourdillon AT, Mehra S, Rahmati R, Judson B, Edwards HA. Anesthesia screen use may impact operating room communication practices in otolaryngology. American Journal Of Otolaryngology 2021, 42: 103000. PMID: 33812208, DOI: 10.1016/j.amjoto.2021.103000.
• Multicenter Study on Clinical Outcomes of Olfactory NeuroblastomaLechner M, Takahashi Y, Hermsen M, Turri-Zanoni M, Schartinger V, Bell D, Helman S, Varghese J, Magliocca K, Dudas J, Riechelmann H, Kaur R, Sprung S, Howard D, Engel N, Zhao T, Liu J, Facchetti F, Maragliano R, Battocchio S, Franchi A, Liu J, Carnell D, Capper D, Schueller U, Forster M, Forde C, Jay A, Manes R, Judson B, Vining E, Woods R, Solares C, O'Neill J, Nicolai P, Surda P, Bossi P, Rampinelli V, Henriquez O, Hopkins C, Thavaraj S, Yarbrough W, London N, Gallia G, Wise S, Llorente J, Castelnuovo P, Hanna E, Lund V. Multicenter Study on Clinical Outcomes of Olfactory Neuroblastoma. Journal Of Neurological Surgery Part B Skull Base 2021, 82: s65-s270. DOI: 10.1055/s-0041-1725285.
• Prolonged inpatient stay after upfront total laryngectomy is associated with overall survivalJacobs D, Kafle S, Earles J, Rahmati R, Mehra S, Judson BL. Prolonged inpatient stay after upfront total laryngectomy is associated with overall survival. Laryngoscope Investigative Otolaryngology 2021, 6: 94-102. PMID: 33614936, PMCID: PMC7883619, DOI: 10.1002/lio2.441.
• Otolaryngology Applicant Characteristics and Trends: Comparing OTO-HNS with Peer SpecialtiesSalehi PP, Heiser A, Salehi P, Torabi SJ, Fine RL, Judson B, Azizzadeh B, Lee YH. Otolaryngology Applicant Characteristics and Trends: Comparing OTO-HNS with Peer Specialties. Annals Of Otology Rhinology & Laryngology 2021, 130: 929-940. PMID: 33435722, DOI: 10.1177/0003489420987408.
• Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United StatesJacobs D, Huang H, Olino K, Weiss S, Kluger H, Judson BL, Zhang Y. Assessment of Age, Period, and Birth Cohort Effects and Trends in Merkel Cell Carcinoma Incidence in the United States. JAMA Dermatology 2021, 157: 59-65. PMID: 33146688, PMCID: PMC7643047, DOI: 10.1001/jamadermatol.2020.4102.
• Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint BlockadeIzreig S, Alzahrani F, Earles J, Mehra S, Judson BL, Pan Z, Rahmati RW. Hyperprogression of a Sinonasal Squamous Cell Carcinoma Following Programmed Cell Death Protein-1 Checkpoint Blockade. JAMA Otolaryngology - Head & Neck Surgery 2020, 146: 1176-1178. PMID: 32940637, DOI: 10.1001/jamaoto.2020.2584.
• Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal CancerJacobs D, Torabi SJ, Park HS, Rahmati R, Young MR, Mehra S, Judson BL. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer. Otolaryngology 2020, 164: 1240-1248. PMID: 33198564, DOI: 10.1177/0194599820969613.
• The role of vitamin D in head and neck cancerIzreig S, Hajek M, Edwards HA, Mehra S, Sasaki C, Judson BL, Rahmati RW. The role of vitamin D in head and neck cancer. Laryngoscope Investigative Otolaryngology 2020, 5: 1079-1088. PMID: 33364397, PMCID: PMC7752058, DOI: 10.1002/lio2.469.
• Sequencing of Sclerosing Microcystic Adenocarcinoma Identifies Mutational Burden and Somatic Variants Associated With TumorigenesisJIANG R, MARQUEZ J, TOWER JI, JACOBS D, CHEN W, MEHRA S, PRASAD ML, JUDSON BL. Sequencing of Sclerosing Microcystic Adenocarcinoma Identifies Mutational Burden and Somatic Variants Associated With Tumorigenesis. Anticancer Research 2020, 40: 6375-6379. PMID: 33109575, DOI: 10.21873/anticanres.14658.
• Ideas and Innovations to Improve the Otolaryngology–Head and Neck Surgery Residency Application and Selection ProcessSalehi PP, Heiser A, Salehi P, Manes RP, Judson BL, Azizzadeh B, Lee YH. Ideas and Innovations to Improve the Otolaryngology–Head and Neck Surgery Residency Application and Selection Process. Otolaryngology 2020, 164: 1001-1010. PMID: 33076735, DOI: 10.1177/0194599820961989.
• Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and NeckJacobs D, Olino K, Park HS, Clune J, Cheraghlou S, Girardi M, Burtness B, Kluger H, Judson BL. Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck. Otolaryngology 2020, 164: 1214-1221. PMID: 33079010, DOI: 10.1177/0194599820967001.
• Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 PandemicBoffa DJ, Judson BL, Billingsley KG, Del Rossi E, Hindinger K, Walters S, Ermer T, Ratner E, Mitchell MR, Laurans MS, Johnson DC, Yoo PS, Morton JM, Zurich HB, Davis K, Ahuja N. Results of COVID-minimal Surgical Pathway During Surge-phase of COVID-19 Pandemic. Annals Of Surgery 2020, 272: e316-e320. PMID: 33086321, PMCID: PMC7668334, DOI: 10.1097/sla.0000000000004455.
• Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomicsHaider SP, Sharaf K, Zeevi T, Baumeister P, Reichel C, Forghani R, Kann BH, Petukhova A, Judson BL, Prasad ML, Liu C, Burtness B, Mahajan A, Payabvash S. Prediction of post-radiotherapy locoregional progression in HPV-associated oropharyngeal squamous cell carcinoma using machine-learning analysis of baseline PET/CT radiomics. Translational Oncology 2020, 14: 100906. PMID: 33075658, PMCID: PMC7568193, DOI: 10.1016/j.tranon.2020.100906.
• Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid CancerJacobs D, Breen CT, Pucar D, Holt E, Judson BL, Mehra S. Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer. Thyroid 2020, 31: 272-279. PMID: 32811347, DOI: 10.1089/thy.2020.0237.
• Prognostic Significance of Extranodal Extension in HPV‐Mediated Oropharyngeal Carcinoma: A Systematic Review and Meta‐analysisBenchetrit L, Torabi SJ, Givi B, Haughey B, Judson BL. Prognostic Significance of Extranodal Extension in HPV‐Mediated Oropharyngeal Carcinoma: A Systematic Review and Meta‐analysis. Otolaryngology 2020, 164: 720-732. PMID: 32838649, DOI: 10.1177/0194599820951176.
• The epidemiology, surgical management, and impact of margins in skull and mandibular osseous‐site tumorsTorabi SJ, Bourdillon A, Salehi PP, Kafle S, Mehra S, Rahmati R, Judson BL. The epidemiology, surgical management, and impact of margins in skull and mandibular osseous‐site tumors. Head & Neck 2020, 42: 3352-3363. PMID: 32743892, DOI: 10.1002/hed.26389.
• A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311Ferris RL, Flamand Y, Holsinger FC, Weinstein GS, Quon H, Mehra R, Garcia JJ, Hinni ML, Gross ND, Sturgis EM, Duvvuri U, Méndez E, Ridge JA, Magnuson JS, Higgins KA, Patel MR, Smith RB, Karakla DW, Kupferman ME, Malone JP, Judson BL, Richmon J, Boyle JO, Bayon R, O'Malley BW, Ozer E, Thomas GR, Koch WM, Bell RB, Saba NF, Li S, Sigurdson ER, Burtness B. A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311. Oral Oncology 2020, 110: 104797. PMID: 32679405, PMCID: PMC7771718, DOI: 10.1016/j.oraloncology.2020.104797.
• Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell CarcinomaHaider SP, Zeevi T, Baumeister P, Reichel C, Sharaf K, Forghani R, Kann BH, Judson BL, Prasad ML, Burtness B, Mahajan A, Payabvash S. Potential Added Value of PET/CT Radiomics for Survival Prognostication beyond AJCC 8th Edition Staging in Oropharyngeal Squamous Cell Carcinoma. Cancers 2020, 12: 1778. PMID: 32635216, PMCID: PMC7407414, DOI: 10.3390/cancers12071778.
• Assessing National Utilization Trends and Outcomes of Robotic and Endoscopic Thyroidectomy in the United StatesJacobs D, Torabi SJ, Gibson C, Rahmati R, Mehra S, Judson BL. Assessing National Utilization Trends and Outcomes of Robotic and Endoscopic Thyroidectomy in the United States. Otolaryngology 2020, 163: 947-955. PMID: 32539533, DOI: 10.1177/0194599820927699.
• Consequences of Medical Hierarchy on Medical Students, Residents, and Medical Education in OtolaryngologySalehi PP, Jacobs D, Suhail‐Sindhu T, Judson BL, Azizzadeh B, Lee YH. Consequences of Medical Hierarchy on Medical Students, Residents, and Medical Education in Otolaryngology. Otolaryngology 2020, 163: 906-914. PMID: 32482121, DOI: 10.1177/0194599820926105.
• Pandemic Recovery Using a COVID-Minimal Cancer Surgery PathwayBoffa DJ, Judson BL, Billingsley KG, Galetta D, Fontanez P, Odermatt C, Lindner K, Mitchell MR, Henderson CM, Carafeno T, Pinto J, Wagner J, Ancuta M, Beley P, Turner AL, Banack T, Laurans MS, Johnson DC, Yoo P, Morton JM, Zurich H, Davis K, Ahuja N. Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway. The Annals Of Thoracic Surgery 2020, 110: 718-724. PMID: 32417195, PMCID: PMC7227551, DOI: 10.1016/j.athoracsur.2020.05.003.
• PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinomaHaider SP, Mahajan A, Zeevi T, Baumeister P, Reichel C, Sharaf K, Forghani R, Kucukkaya AS, Kann BH, Judson BL, Prasad ML, Burtness B, Payabvash S. PET/CT radiomics signature of human papilloma virus association in oropharyngeal squamous cell carcinoma. European Journal Of Nuclear Medicine And Molecular Imaging 2020, 47: 2978-2991. PMID: 32399621, DOI: 10.1007/s00259-020-04839-2.
• Outpatient Otolaryngology in the Era of COVID‐19: A Data‐Driven Analysis of Practice PatternsKasle DA, Torabi SJ, Savoca EL, Judson BL, Manes RP. Outpatient Otolaryngology in the Era of COVID‐19: A Data‐Driven Analysis of Practice Patterns. Otolaryngology 2020, 163: 138-144. PMID: 32393101, PMCID: PMC7218354, DOI: 10.1177/0194599820928987.
• Entwicklung bildbasierter Radiomics-Biomarker für den Humanen Papillomavirus (HPV)-Status beim oropharyngealen Plattenepithelkarzinom (OPSCC) mittels Machine-Learning-AlgorithmenHaider S, Mahajan A, Zeevi T, Forghani R, Kann B, Judson B, Burtness B, Sharaf K, Reichel C, Baumeister P, Payabvash S. Entwicklung bildbasierter Radiomics-Biomarker für den Humanen Papillomavirus (HPV)-Status beim oropharyngealen Plattenepithelkarzinom (OPSCC) mittels Machine-Learning-Algorithmen. Laryngo-Rhino-Otologie 2020, 99: s116. DOI: 10.1055/s-0040-1711657.
• Devising novel imaging biomarkers for Human Papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC): applying radiomics and machine learning algorithmsHaider S, Mahajan A, Zeevi T, Forghani R, Kann B, Judson B, Burtness B, Sharaf K, Reichel C, Baumeister P, Payabvash S. Devising novel imaging biomarkers for Human Papillomavirus (HPV) status in oropharyngeal squamous cell carcinoma (OPSCC): applying radiomics and machine learning algorithms. Laryngo-Rhino-Otologie 2020, 99: s163. DOI: 10.1055/s-0040-1711024.
• Changing Demographics of Laryngeal Cancer: Are Patients Getting Younger?Jacobs D, Park H, Rahmati R, Mehra S, Judson B. Changing Demographics of Laryngeal Cancer: Are Patients Getting Younger? International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1162-1163. DOI: 10.1016/j.ijrobp.2019.11.186.
• An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based AnalysisJacobs D, Park H, Young M, Breen C, Rahmati R, Mehra S, Judson B. An Update on Trends and Disparities in Utilization of Total Laryngectomy: a Population-Based Analysis. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1145-1146. DOI: 10.1016/j.ijrobp.2019.11.214.
• Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and NeckJacobs D, Park H, Young M, Olino K, Rahmati R, Mehra S, Burtness B, Judson B. Assessment of Lymph Node Evaluation in Patients with Clinically Node Negative Merkel Cell Carcinoma of the Head and Neck. International Journal Of Radiation Oncology • Biology • Physics 2020, 106: 1191-1192. DOI: 10.1016/j.ijrobp.2019.11.099.
• Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancerSaeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer. Head & Neck 2020, 42: 1031-1044. PMID: 32011055, DOI: 10.1002/hed.26086.
• Clinical characteristics and treatment‐associated survival of head and neck Ewing sarcomaTorabi SJ, Izreig S, Kasle DA, Benchetrit L, Salehi PP, Judson BL. Clinical characteristics and treatment‐associated survival of head and neck Ewing sarcoma. The Laryngoscope 2019, 130: 2385-2392. PMID: 31774563, DOI: 10.1002/lary.28412.
• Margins in Sinonasal Squamous Cell Carcinoma: Predictors, Outcomes, and the Endoscopic ApproachTorabi SJ, Spock T, Cardoso B, Chao J, Morse E, Manes RP, Judson BL. Margins in Sinonasal Squamous Cell Carcinoma: Predictors, Outcomes, and the Endoscopic Approach. The Laryngoscope 2019, 130: e388-e396. PMID: 31755988, DOI: 10.1002/lary.28315.
• Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant TherapyLOGANADANE G, KANN BH, PARK HS, JOHNSON SB, MEHRA S, JUDSON BL, BHATIA A, BELKACEMI Y, YARBROUGH WG, BURTNESS B, HUSAIN ZA. Clinical Outcomes of Head and Neck Cancer Patients Who Undergo Resection, But Forgo Adjuvant Therapy. Anticancer Research 2019, 39: 4885-4890. PMID: 31519591, DOI: 10.21873/anticanres.13674.
• Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant TherapyLoganadane G, Kann B, Park H, Johnson S, Mehra S, Judson B, Bhatia A, Belkacemi Y, Yarbrough W, Burtness B, Husain Z. Clinical Outcomes of Head and Neck Cancer Patients who Undergo Resection, but Forgo Adjuvant Therapy. International Journal Of Radiation Oncology • Biology • Physics 2019, 105: e375-e376. DOI: 10.1016/j.ijrobp.2019.06.1628.
• The Smilow Cancer Hospital Oncology Extended Care Clinic: A Facility Dedicated to Managing Oncologic Urgencies and EmergenciesRothberg B, Dest V, Raucci M, Carafeno T, Sinanis N, Strait M, Judson B, Adelson K. The Smilow Cancer Hospital Oncology Extended Care Clinic: A Facility Dedicated to Managing Oncologic Urgencies and Emergencies. Journal Of Emergency Medicine 2019, 57: 424. DOI: 10.1016/j.jemermed.2019.04.007.
• Preoperative biopsy in parotid malignancies: Variation in use and impact on surgical marginsBenchetrit L, Torabi SJ, Morse E, Mehra S, Rahmati R, Osborn HA, Judson BL. Preoperative biopsy in parotid malignancies: Variation in use and impact on surgical margins. The Laryngoscope 2019, 130: 1450-1458. PMID: 31411749, DOI: 10.1002/lary.28224.
• Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell CarcinomaTorabi SJ, Benchetrit L, Yu P, Cheraghlou S, Savoca EL, Tate JP, Judson BL. Prognostic Case Volume Thresholds in Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngology - Head & Neck Surgery 2019, 145: 708-715. PMID: 31194229, PMCID: PMC6567848, DOI: 10.1001/jamaoto.2019.1187.
• Is robotic surgery an option for early T‐stage laryngeal cancer? Early nationwide resultsHanna J, Brauer PR, Morse E, Judson B, Mehra S. Is robotic surgery an option for early T‐stage laryngeal cancer? Early nationwide results. The Laryngoscope 2019, 130: 1195-1201. PMID: 31233223, DOI: 10.1002/lary.28144.
• Positive Surgical Margins in Submandibular Malignancies: Facility and Practice VariationBenchetrit L, Morse E, Judson BL, Mehra S. Positive Surgical Margins in Submandibular Malignancies: Facility and Practice Variation. Otolaryngology 2019, 161: 620-628. PMID: 31159649, DOI: 10.1177/0194599819852094.
• Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatmentBenchetrit L, Torabi SJ, Tate JP, Mehra S, Osborn HA, Young MR, Burtness B, Judson BL. Gender disparities in head and neck cancer chemotherapy clinical trials participation and treatment. Oral Oncology 2019, 94: 32-40. PMID: 31178210, DOI: 10.1016/j.oraloncology.2019.05.009.
• Positive margin rates and predictors in transoral robotic surgery after federal approval: A national quality studyHanna J, Morse E, Brauer PR, Judson B, Mehra S. Positive margin rates and predictors in transoral robotic surgery after federal approval: A national quality study. Head & Neck 2019, 41: 3064-3072. PMID: 31058417, DOI: 10.1002/hed.25792.
• Multi-modality Treatment and Survival in Sinonasal Minor Salivary Gland TumorsTorabi SJ, Spock T, Cardoso B, Chao J, Manes RP, Judson BL. Multi-modality Treatment and Survival in Sinonasal Minor Salivary Gland Tumors. Journal Of Neurological Surgery Part B Skull Base 2019, 81: 198-205. PMID: 32206540, PMCID: PMC7082160, DOI: 10.1055/s-0039-1683437.
• OA01 Impact of Contralateral Lymph Node Involvement on Survival of Surgically-Managed HPV-Positive Oropharyngeal Cancer Staged with the AJCC Eighth EditionMiccio J, Kelly J, Kann B, An Y, Park H, Verma V, Mehra S, Judson B, Burtness B, Husain Z. OA01 Impact of Contralateral Lymph Node Involvement on Survival of Surgically-Managed HPV-Positive Oropharyngeal Cancer Staged with the AJCC Eighth Edition. International Journal Of Radiation Oncology • Biology • Physics 2019, 103: e1. DOI: 10.1016/s0360-3016(19)30402-x.
• Clinically node-negative head and neck mucosal melanoma: An analysis of current treatment guidelines & outcomesTorabi SJ, Benchetrit L, Spock T, Cheraghlou S, Judson BL. Clinically node-negative head and neck mucosal melanoma: An analysis of current treatment guidelines & outcomes. Oral Oncology 2019, 92: 67-76. PMID: 31010627, DOI: 10.1016/j.oraloncology.2019.03.017.
• Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinomaLee NCJ, Kelly JR, An Y, Park HS, Judson BL, Burtness BA, Husain ZA. Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma. Cancer 2019, 125: 2018-2026. PMID: 30748002, PMCID: PMC6541535, DOI: 10.1002/cncr.32001.
• Multimodality Treatment and Survival in Sinonasal Minor Salivary Gland TumorsTorabi S, Spock T, Cardoso B, Chao J, Manes R, Judson B. Multimodality Treatment and Survival in Sinonasal Minor Salivary Gland Tumors. Journal Of Neurological Surgery Part B Skull Base 2019, 80: s1-s244. DOI: 10.1055/s-0039-1679617.
• Nonsquamous cell laryngeal cancers: Incidence, demographics, care patterns, and effect of surgeryTorabi SJ, Cheraghlou S, Kasle DA, Savoca EL, Judson BL. Nonsquamous cell laryngeal cancers: Incidence, demographics, care patterns, and effect of surgery. The Laryngoscope 2019, 129: 2496-2505. PMID: 30632157, DOI: 10.1002/lary.27785.
• Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoptionLi H, Torabi SJ, Park HS, Yarbrough WG, Mehra S, Choi R, Judson BL. Clinical value of transoral robotic surgery: Nationwide results from the first 5 years of adoption. The Laryngoscope 2018, 129: 1844-1855. PMID: 30575965, DOI: 10.1002/lary.27740.
• Adjuvant External Beam Radiation Therapy for Surgically Resected, Non-Metastatic Anaplastic Thyroid CancerSaeed N, Kelly J, Deshpande H, Bhatia A, Burtness B, Judson B, Mehra S, Osborn H, Yarbrough W, Peter P, Holt E, Decker R, Husain Z, Park H. Adjuvant External Beam Radiation Therapy for Surgically Resected, Non-Metastatic Anaplastic Thyroid Cancer. International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e290-e291. DOI: 10.1016/j.ijrobp.2018.07.923.
• Hypopharyngeal Cancer Treatment Delays: Benchmarks and Survival AssociationMorse E, Berson E, Fujiwara R, Judson B, Mehra S. Hypopharyngeal Cancer Treatment Delays: Benchmarks and Survival Association. Otolaryngology 2018, 160: 267-276. PMID: 30324861, DOI: 10.1177/0194599818797605.
• Survival Outcomes for Induction vs Adjuvant Chemotherapy in Squamous Cell Carcinoma of the Maxillary SinusKuo P, Torabi SJ, Kraus D, Judson BL. Survival Outcomes for Induction vs Adjuvant Chemotherapy in Squamous Cell Carcinoma of the Maxillary Sinus. Otolaryngology 2018, 160: 658-663. PMID: 30296902, DOI: 10.1177/0194599818804777.
• Positive surgical margins in parotid malignancies: Institutional variation and survival associationMorse E, Fujiwara RJT, Judson B, Prasad ML, Mehra S. Positive surgical margins in parotid malignancies: Institutional variation and survival association. The Laryngoscope 2018, 129: 129-137. PMID: 30194762, DOI: 10.1002/lary.27221.
• Changing prognosis of oral cancer: An analysis of survival and treatment between 1973 and 2014Cheraghlou S, Schettino A, Zogg CK, Judson BL. Changing prognosis of oral cancer: An analysis of survival and treatment between 1973 and 2014. The Laryngoscope 2018, 128: 2762-2769. PMID: 30194691, DOI: 10.1002/lary.27315.
• HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomesCheraghlou S, Torabi SJ, Husain ZA, Otremba MD, Osborn HA, Mehra S, Yarbrough WG, Burtness BA, Judson BL. HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes. The Laryngoscope 2018, 129: 684-691. PMID: 30151832, DOI: 10.1002/lary.27475.
• Adjuvant Chemotherapy Is Associated With Improved Survival for Late‐Stage Salivary Squamous Cell CarcinomaCheraghlou S, Schettino A, Zogg CK, Otremba MD, Bhatia A, Park HS, Osborn HA, Mehra S, Yarbrough WG, Judson BL. Adjuvant Chemotherapy Is Associated With Improved Survival for Late‐Stage Salivary Squamous Cell Carcinoma. The Laryngoscope 2018, 129: 883-889. PMID: 30151947, DOI: 10.1002/lary.27444.
• Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinomaLee NCJ, Kelly JR, Park HS, An Y, Judson BL, Burtness BA, Husain ZA. Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma. Oral Oncology 2018, 85: 35-39. PMID: 30220317, DOI: 10.1016/j.oraloncology.2018.08.001.
• A Clinical Care Pathway to Reduce ICU Usage in Head and Neck Microvascular ReconstructionMorse E, Henderson C, Carafeno T, Dibble J, Longley P, Chan E, Judson B, Yarbrough WG, Sasaki C, Mehra S. A Clinical Care Pathway to Reduce ICU Usage in Head and Neck Microvascular Reconstruction. Otolaryngology 2018, 160: 783-790. PMID: 30060705, DOI: 10.1177/0194599818782404.
• Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival AssociationsMorse E, Judson B, Husain Z, Burtness B, Yarbrough WG, Sasaki C, Cheraghlou S, Mehra S. Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival Associations. Otolaryngology 2018, 159: 987-997. PMID: 30060700, DOI: 10.1177/0194599818779052.
• Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glandsCheraghlou S, Yu PK, Otremba MD, Mehra S, Yarbrough WG, Judson BL. Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands. Cancers Of The Head & Neck 2018, 3: 5. PMID: 31093358, PMCID: PMC6460801, DOI: 10.1186/s41199-018-0032-x.
• Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomasLi H, Park HS, Osborn HA, Judson BL. Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas. Cancers Of The Head & Neck 2018, 3: 4. PMID: 31093357, PMCID: PMC6460664, DOI: 10.1186/s41199-018-0031-y.
• Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall SurvivalLi H, Torabi SJ, Yarbrough WG, Mehra S, Osborn HA, Judson B. Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival. JAMA Otolaryngology - Head & Neck Surgery 2018, 144: 519-525. PMID: 29801040, PMCID: PMC6583856, DOI: 10.1001/jamaoto.2018.0395.
• National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiationMorse E, Judson B, Husain Z, Burtness B, Yarbrough W, Sasaki C, Cheraghlou S, Mehra S. National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation. Oral Oncology 2018, 82: 122-130. PMID: 29909886, DOI: 10.1016/j.oraloncology.2018.02.010.
• Treatment delays in laryngeal squamous cell carcinoma: A national cancer database analysisMorse E, Fujiwara RJT, Judson B, Mehra S. Treatment delays in laryngeal squamous cell carcinoma: A national cancer database analysis. The Laryngoscope 2018, 128: 2751-2758. PMID: 29756382, DOI: 10.1002/lary.27247.
• Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer DatabaseCheraghlou S, Kuo P, Mehra S, Agogo GO, Bhatia A, Husain ZA, Yarbrough WG, Burtness BA, Judson BL. Adjuvant therapy in major salivary gland cancers: Analysis of 8580 patients in the National Cancer Database. Head & Neck 2018, 40: 1343-1355. PMID: 29756412, DOI: 10.1002/hed.24984.
• Association of Facility and System Factors With Survival Among Pediatric Patients With Surgically Treated Head and Neck SarcomasCheraghlou S, Li H, Judson BL. Association of Facility and System Factors With Survival Among Pediatric Patients With Surgically Treated Head and Neck Sarcomas. JAMA Otolaryngology - Head & Neck Surgery 2018, 144: 455-456. PMID: 29800240, PMCID: PMC6136052, DOI: 10.1001/jamaoto.2018.0183.
• Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with SurvivalMorse E, Fujiwara RJT, Husain Z, Judson B, Mehra S. Pediatric Salivary Cancer: Epidemiology, Treatment Trends, and Association of Treatment Modality with Survival. Otolaryngology 2018, 159: 553-563. PMID: 29688836, DOI: 10.1177/0194599818771926.
• Lymph Node Yield as Quality Metric for Clinically N0 Oral CancerJudson BL. Lymph Node Yield as Quality Metric for Clinically N0 Oral Cancer. JAMA Otolaryngology - Head & Neck Surgery 2018, 144: 386. PMID: 29494723, DOI: 10.1001/jamaoto.2017.3333.
• Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancerKelly JR, Park HS, An Y, Yarbrough WG, Contessa JN, Decker R, Mehra S, Judson BL, Burtness B, Husain Z. Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer. Oral Oncology 2018, 79: 64-70. PMID: 29598952, DOI: 10.1016/j.oraloncology.2018.02.017.
• Treatment Times in Salivary Gland Cancer: National Patterns and Association with SurvivalMorse E, Fujiwara RJT, Judson B, Mehra S. Treatment Times in Salivary Gland Cancer: National Patterns and Association with Survival. Otolaryngology 2018, 159: 283-292. PMID: 29460669, DOI: 10.1177/0194599818758020.
• Prognostic Value of Lymph Node Yield and Density in Head and Neck MalignanciesCheraghlou S, Otremba M, Yu P, Agogo GO, Hersey D, Judson BL. Prognostic Value of Lymph Node Yield and Density in Head and Neck Malignancies. Otolaryngology 2018, 158: 1016-1023. PMID: 29460685, DOI: 10.1177/0194599818756830.
• Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation SurgeryCheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Salvage Surgery after Radiation Failure in T1/T2 Larynx Cancer: Outcomes following Total versus Conservation Surgery. Otolaryngology 2018, 158: 497-504. PMID: 29292665, DOI: 10.1177/0194599817742596.
• Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data BaseCheraghlou S, Yu PK, Otremba MD, Park HS, Bhatia A, Zogg CK, Mehra S, Yarbrough WG, Judson BL. Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data Base. Cancer 2017, 124: 717-726. PMID: 29243245, DOI: 10.1002/cncr.31104.
• Demethylation Therapy as a Targeted Treatment for Human Papillomavirus–Associated Head and Neck CancerBiktasova A, Hajek M, Sewell A, Gary C, Bellinger G, Deshpande HA, Bhatia A, Burtness B, Judson B, Mehra S, Yarbrough WG, Issaeva N. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus–Associated Head and Neck Cancer. Clinical Cancer Research 2017, 23: 7276-7287. PMID: 28916527, DOI: 10.1158/1078-0432.ccr-17-1438.
• The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinomaSchutt CA, Mirandola L, Figueroa JA, Nguyen DD, Cordero J, Bumm K, Judson BL, Chiriva-Internati M. The cancer-testis antigen, sperm protein 17, a new biomarker and immunological target in head and neck squamous cell carcinoma. Oncotarget 2017, 5: 100280-100287. PMID: 29245977, PMCID: PMC5725019, DOI: 10.18632/oncotarget.22213.
• Leiomyosarcoma of the infratemporal fossa with perineurial spread along the right mandibular nerve: a case reportBarbiero FJ, Huttner AJ, Judson BL, Baehring JM. Leiomyosarcoma of the infratemporal fossa with perineurial spread along the right mandibular nerve: a case report. CNS Oncology 2017, 06: 281-285. PMID: 28990793, PMCID: PMC6004886, DOI: 10.2217/cns-2017-0004.
• Thirty‐day morbidity and mortality following otologic/neurotologic surgery: Analysis of the national surgical quality improvement programSchwam ZG, Michaelides E, Kuo P, Hajek MA, Judson BL, Schutt C. Thirty‐day morbidity and mortality following otologic/neurotologic surgery: Analysis of the national surgical quality improvement program. The Laryngoscope 2017, 128: 1431-1437. PMID: 28940480, DOI: 10.1002/lary.26848.
• Untreated oral cavity cancer: Long‐term survival and factors associated with treatment refusalCheraghlou S, Kuo P, Mehra S, Yarbrough WG, Judson BL. Untreated oral cavity cancer: Long‐term survival and factors associated with treatment refusal. The Laryngoscope 2017, 128: 664-669. PMID: 28865100, DOI: 10.1002/lary.26809.
• MAMMARY ANALOGUE SECRETORY CARCINOMA (MASC) OF THE LOWER LIP IN A PEDIATRIC PATIENTHABERLAND C, MUKAND-CERRO I, ZHANG X, PRASAD M, WILK A, JUDSON B, GNEPP D. MAMMARY ANALOGUE SECRETORY CARCINOMA (MASC) OF THE LOWER LIP IN A PEDIATRIC PATIENT. Oral Surgery Oral Medicine Oral Pathology And Oral Radiology 2017, 124: e219. DOI: 10.1016/j.oooo.2017.06.071.
• Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatmentFujiwara RJT, Burtness B, Husain ZA, Judson BL, Bhatia A, Sasaki CT, Yarbrough WG, Mehra S. Treatment guidelines and patterns of care in oral cavity squamous cell carcinoma: Primary surgical resection vs. nonsurgical treatment. Oral Oncology 2017, 71: 129-137. PMID: 28688680, DOI: 10.1016/j.oraloncology.2017.06.013.
• Comparing 30‐Day Morbidity and Mortality in Pediatric and Adult Otologic SurgerySchwam ZG, Michaelides E, Schwam JR, Kuo P, Hajek MA, Judson BL, Schutt C. Comparing 30‐Day Morbidity and Mortality in Pediatric and Adult Otologic Surgery. Otolaryngology 2017, 157: 830-836. PMID: 28463634, DOI: 10.1177/0194599817704376.
• Response to nivolumab in radiation induced, BRCA-2 N372H variant, programed death ligand-1 negative, pleomorphic undifferentiated sarcoma.Foster Y, Cecchini M, Slater D, Neumeister V, Walther Z, Husain Z, Judson B, Deshpande H. Response to nivolumab in radiation induced, BRCA-2 N372H variant, programed death ligand-1 negative, pleomorphic undifferentiated sarcoma. Journal Of Clinical Oncology 2017, 35: 61-61. DOI: 10.1200/jco.2017.35.7_suppl.61.
• A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell CarcinomaHusain ZA, Chen T, Corso CD, Wang Z, Park H, Judson B, Yarbrough W, Deshpande H, Mehra S, Kuo P, Decker RH, Burtness BA. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus–Related Oropharyngeal Squamous Cell Carcinoma. JAMA Oncology 2017, 3: 358-365. PMID: 27737449, DOI: 10.1001/jamaoncol.2016.4581.
• Treatment delays in oral cavity squamous cell carcinoma and association with survivalFujiwara RJ, Judson BL, Yarbrough WG, Husain Z, Mehra S. Treatment delays in oral cavity squamous cell carcinoma and association with survival. Head & Neck 2017, 39: 639-646. PMID: 28236349, DOI: 10.1002/hed.24608.
• Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated CarcinomaKuo P, Manes RP, Schwam ZG, Judson BL. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma. Otolaryngology 2016, 156: 132-136. PMID: 27703092, DOI: 10.1177/0194599816670146.
• Comparison of Upfront Surgery Versus Chemoradiation for cT1-2 N1-2b Oropharynx Squamous Cell Carcinoma Based on Human Papillomavirus StatusKelly J, Park H, An Y, Decker R, Contessa J, Yarbrough W, Burtness B, Judson B, Husain Z. Comparison of Upfront Surgery Versus Chemoradiation for cT1-2 N1-2b Oropharynx Squamous Cell Carcinoma Based on Human Papillomavirus Status. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e327. DOI: 10.1016/j.ijrobp.2016.06.1451.
• Treatment delay and facility case volume are associated with survival in early‐stage glottic cancerCheraghlou S, Kuo P, Judson BL. Treatment delay and facility case volume are associated with survival in early‐stage glottic cancer. The Laryngoscope 2016, 127: 616-622. PMID: 27653749, DOI: 10.1002/lary.26259.
• Proposing prognostic thresholds for lymph node yield in clinically lymph node‐negative and lymph node‐positive cancers of the oral cavityKuo P, Mehra S, Sosa JA, Roman SA, Husain ZA, Burtness BA, Tate JP, Yarbrough WG, Judson BL. Proposing prognostic thresholds for lymph node yield in clinically lymph node‐negative and lymph node‐positive cancers of the oral cavity. Cancer 2016, 122: 3624-3631. PMID: 27479645, DOI: 10.1002/cncr.30227.
• Radiotherapy for human papillomavirus‐positive oropharyngeal cancers in the National Cancer Data BaseCheraghlou S, Kuo P, Judson BL. Radiotherapy for human papillomavirus‐positive oropharyngeal cancers in the National Cancer Data Base. Cancer 2016, 122: 3410-3410. PMID: 27420896, DOI: 10.1002/cncr.30195.
• Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control studySubramanian HE, Park HS, Barbieri A, Mahajan A, Judson BL, Mehra S, Yarbrough WG, Burtness BA, Husain ZA. Pretreatment predictors of adjuvant chemoradiation in patients receiving transoral robotic surgery for squamous cell carcinoma of the oropharynx: a case control study. Cancers Of The Head & Neck 2016, 1: 7. PMID: 31093337, PMCID: PMC6460847, DOI: 10.1186/s41199-016-0008-7.
• Reply to smoking cessation for patients with cancer: “The Emperor's New Clothes”Ramaswamy AT, Toll B, Chagpar AB, Judson BL. Reply to smoking cessation for patients with cancer: “The Emperor's New Clothes”. Cancer 2016, 122: 2926-2926. PMID: 27285587, DOI: 10.1002/cncr.30152.
• NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic CarcinomaPanaccione A, Chang MT, Carbone BE, Guo Y, Moskaluk CA, Virk RK, Chiriboga L, Prasad ML, Judson B, Mehra S, Yarbrough WG, Ivanov SV. NOTCH1 and SOX10 are Essential for Proliferation and Radiation Resistance of Cancer Stem–Like Cells in Adenoid Cystic Carcinoma. Clinical Cancer Research 2016, 22: 2083-2095. PMID: 27084744, PMCID: PMC4834904, DOI: 10.1158/1078-0432.ccr-15-2208.
• Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data BaseKuo P, Sosa JA, Burtness BA, Husain ZA, Mehra S, Roman SA, Yarbrough WG, Judson BL. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base. Cancer 2016, 122: 1853-1860. PMID: 27019213, DOI: 10.1002/cncr.29962.
• Smoking, cessation, and cessation counseling in patients with cancer: A population‐based analysisRamaswamy AT, Toll BA, Chagpar AB, Judson BL. Smoking, cessation, and cessation counseling in patients with cancer: A population‐based analysis. Cancer 2016, 122: 1247-1253. PMID: 26881851, DOI: 10.1002/cncr.29851.
• Receipt of Care Discordant with Practice Guidelines is Associated with Compromised Overall Survival in Nasopharyngeal CarcinomaSchwam ZG, Sosa JA, Roman S, Judson BL. Receipt of Care Discordant with Practice Guidelines is Associated with Compromised Overall Survival in Nasopharyngeal Carcinoma. Clinical Oncology 2016, 28: 402-409. PMID: 26868285, DOI: 10.1016/j.clon.2016.01.010.
• Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in MozambiqueBlumberg J, Monjane L, Prasad M, Carrilho C, Judson BL. Investigation of the presence of HPV related oropharyngeal and oral tongue squamous cell carcinoma in Mozambique. Cancer Epidemiology 2015, 39: 1000-1005. PMID: 26590333, PMCID: PMC6384508, DOI: 10.1016/j.canep.2015.10.015.
• Improved prognosis for patients with oral cavity squamous cell carcinoma: Analysis of the National Cancer Database 1998–2006Schwam ZG, Judson BL. Improved prognosis for patients with oral cavity squamous cell carcinoma: Analysis of the National Cancer Database 1998–2006. Oral Oncology 2015, 52: 45-51. PMID: 26553389, DOI: 10.1016/j.oraloncology.2015.10.012.
• Refusal of postoperative radiotherapy and its association with survival in head and neck cancerSchwam ZG, Husain Z, Judson BL. Refusal of postoperative radiotherapy and its association with survival in head and neck cancer. Radiotherapy And Oncology 2015, 117: 343-350. PMID: 26508285, DOI: 10.1016/j.radonc.2015.10.013.
• National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer DatabaseSchwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL. National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database. Cancer Medicine 2015, 4: 1828-1835. PMID: 26471244, PMCID: PMC5123708, DOI: 10.1002/cam4.546.
• Severe epistaxis due to aberrant vasculature in a patient with STAT‐1 mutationChang MT, Schwam ZG, Hajek MA, Paskhover B, Judson BL. Severe epistaxis due to aberrant vasculature in a patient with STAT‐1 mutation. Head & Neck 2015, 38: e68-e70. PMID: 26445901, DOI: 10.1002/hed.24165.
• Hospital readmission and 30‐day mortality after surgery for oral cavity cancer: Analysis of 21,681 casesLuryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Hospital readmission and 30‐day mortality after surgery for oral cavity cancer: Analysis of 21,681 cases. Head & Neck 2015, 38: e221-e226. PMID: 25537226, DOI: 10.1002/hed.23973.
• Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data BaseLuryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base. JAMA Otolaryngology - Head & Neck Surgery 2015, 141: 593-598. PMID: 25974757, DOI: 10.1001/jamaoto.2015.0719.
• Complications and mortality following surgery for oral cavity cancer: Analysis of 408 casesSchwam ZG, Sosa JA, Roman S, Judson BL. Complications and mortality following surgery for oral cavity cancer: Analysis of 408 cases. The Laryngoscope 2015, 125: 1869-1873. PMID: 26063059, DOI: 10.1002/lary.25328.
• Cost effectiveness of transoral robotic surgery for the treatment of oropharyngeal squamous cell carcinoma: a systematic reviewJudson B, Aaronson N, Neubauer P. Cost effectiveness of transoral robotic surgery for the treatment of oropharyngeal squamous cell carcinoma: a systematic review. Robotic Surgery Research And Reviews 2015, Volume 2: 59-63. DOI: 10.2147/rsrr.s64869.
• The Role of Adjuvant Therapy in the Management of Head and Neck Merkel Cell CarcinomaChen MM, Roman SA, Sosa JA, Judson BL. The Role of Adjuvant Therapy in the Management of Head and Neck Merkel Cell Carcinoma. JAMA Otolaryngology - Head & Neck Surgery 2015, 141: 137. PMID: 25474617, DOI: 10.1001/jamaoto.2014.3052.
• Database and Registry Research in Thyroid Cancer: Striving for a New and Improved National Thyroid Cancer DatabaseMehra S, Tuttle RM, Milas M, Orloff L, Bergman D, Bernet V, Brett E, Cobin R, Doherty G, Judson BL, Klopper J, Lee S, Lupo M, Machac J, Mechanick JI, Randolph G, Ross DS, Smallridge R, Terris D, Tufano R, Alon E, Clain J, DosReis L, Scherl S, Urken ML. Database and Registry Research in Thyroid Cancer: Striving for a New and Improved National Thyroid Cancer Database. Thyroid 2015, 25: 157-168. PMID: 25517683, DOI: 10.1089/thy.2014.0270.
• Predictors of Survival in Sinonasal AdenocarcinomaChen MM, Roman SA, Sosa JA, Judson BL. Predictors of Survival in Sinonasal Adenocarcinoma. Journal Of Neurological Surgery Part B Skull Base 2015, 76: 208-213. PMID: 26225303, PMCID: PMC4433397, DOI: 10.1055/s-0034-1543995.
• Vascular malformation with phleboliths involving the parotid gland: A case report with a review of the literature.Ho C, Judson BL, Prasad ML. Vascular malformation with phleboliths involving the parotid gland: A case report with a review of the literature. Ear, Nose & Throat Journal 2015, 94: e1-5. PMID: 26535823.
• Intraoperative Vagus Nerve Monitoring: A Transnasal Technique during Skull Base SurgerySchutt CA, Paskhover B, Judson BL. Intraoperative Vagus Nerve Monitoring: A Transnasal Technique during Skull Base Surgery. Journal Of Neurological Surgery Part B Skull Base 2014, 76: 087-089. PMID: 25844292, PMCID: PMC4375050, DOI: 10.1055/s-0034-1390404.
• Positive Surgical Margins in Early Stage Oral Cavity Cancer: An Analysis of 20,602 CasesLuryi AL, Chen MM, Mehra S, Roman SA, Sosa JA, Judson BL. Positive Surgical Margins in Early Stage Oral Cavity Cancer: An Analysis of 20,602 Cases. Otolaryngology 2014, 151: 984-990. PMID: 25257901, DOI: 10.1177/0194599814551718.
• Factors Associated with the Use of Intensity‐Modulated Radiotherapy for Head and Neck CancerChen M, Roman S, Sosa J, Judson B. Factors Associated with the Use of Intensity‐Modulated Radiotherapy for Head and Neck Cancer. Otolaryngology 2014, 151: p164-p164. DOI: 10.1177/0194599814541629a85.
• Surgical management of parapharyngeal space infectionsBlumberg J, Judson B. Surgical management of parapharyngeal space infections. Operative Techniques In Otolaryngology-Head And Neck Surgery 2014, 25: 304-309. DOI: 10.1016/j.otot.2014.04.014.
• Esophageal perforation caused by edible foreign bodies: A systematic review of the literatureAronberg RM, Punekar SR, Adam SI, Judson BL, Mehra S, Yarbrough WG. Esophageal perforation caused by edible foreign bodies: A systematic review of the literature. The Laryngoscope 2014, 125: 371-378. PMID: 25155167, DOI: 10.1002/lary.24899.
• Trends and variations in the use of adjuvant therapy for patients with head and neck cancerChen MM, Roman SA, Yarbrough WG, Burtness BA, Sosa JA, Judson BL. Trends and variations in the use of adjuvant therapy for patients with head and neck cancer. Cancer 2014, 120: 3353-3360. PMID: 25042524, DOI: 10.1002/cncr.28870.
• Public Awareness of Head and Neck Cancers: A Cross-Sectional SurveyLuryi AL, Yarbrough WG, Niccolai LM, Roser S, Reed SG, Nathan CA, Moore MG, Day T, Judson BL. Public Awareness of Head and Neck Cancers: A Cross-Sectional Survey. JAMA Otolaryngology - Head & Neck Surgery 2014, 140: 639-646. PMID: 24902640, DOI: 10.1001/jamaoto.2014.867.
• Hypopharyngeal cancer incidence, treatment, and survival: Temporal trends in the United StatesKuo P, Chen MM, Decker RH, Yarbrough WG, Judson BL. Hypopharyngeal cancer incidence, treatment, and survival: Temporal trends in the United States. The Laryngoscope 2014, 124: 2064-2069. PMID: 25295351, DOI: 10.1002/lary.24651.
• Predictors of survival in carcinoma ex pleomorphic adenomaChen MM, Roman SA, Sosa JA, Judson BL. Predictors of survival in carcinoma ex pleomorphic adenoma. Head & Neck 2014, 36: 1324-1328. PMID: 23956034, DOI: 10.1002/hed.23453.
• Transoral Robotic Surgery: A Population‐Level AnalysisChen MM, Roman SA, Kraus DH, Sosa JA, Judson BL. Transoral Robotic Surgery: A Population‐Level Analysis. Otolaryngology 2014, 150: 968-975. PMID: 24618503, DOI: 10.1177/0194599814525747.
• Safety of Adult Tonsillectomy: A Population-Level Analysis of 5968 PatientsChen MM, Roman SA, Sosa JA, Judson BL. Safety of Adult Tonsillectomy: A Population-Level Analysis of 5968 Patients. JAMA Otolaryngology - Head & Neck Surgery 2014, 140: 197-202. PMID: 24481159, DOI: 10.1001/jamaoto.2013.6215.
• Predictors of Survival in Sinonasal AdenocarcinomaChen M, Roman S, Sosa J, Judson B. Predictors of Survival in Sinonasal Adenocarcinoma. Journal Of Neurological Surgery Part B Skull Base 2014, 75 DOI: 10.1055/s-0034-1370477.
• Prognostic factors for squamous cell cancer of the parotid gland: An analysis of 2104 patientsChen MM, Roman SA, Sosa JA, Judson BL. Prognostic factors for squamous cell cancer of the parotid gland: An analysis of 2104 patients. Head & Neck 2014, 37: 1-7. PMID: 24339135, DOI: 10.1002/hed.23566.
• Postdischarge Complications Predict Reoperation and Mortality after Otolaryngologic SurgeryChen MM, Roman SA, Sosa JA, Judson BL. Postdischarge Complications Predict Reoperation and Mortality after Otolaryngologic Surgery. Otolaryngology 2013, 149: 865-872. PMID: 24047818, DOI: 10.1177/0194599813505078.
• Post‐discharge Complications Predict Reoperation and Mortality after Otolaryngology SurgeryChen M, Roman S, Sosa J, Judson B. Post‐discharge Complications Predict Reoperation and Mortality after Otolaryngology Surgery. Otolaryngology 2013, 149: p51-p51. DOI: 10.1177/0194599813495815a56.
• Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population‐level analysis of 2400 patientsChen MM, Roman SA, Sosa JA, Judson BL. Histologic grade as prognostic indicator for mucoepidermoid carcinoma: A population‐level analysis of 2400 patients. Head & Neck 2013, 36: 158-163. PMID: 23765800, DOI: 10.1002/hed.23256.
• Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes.Marrone K, Otremba M, Groisberg R, Deshpande H, Crawford F, Acevedo-Gadea C, Gould Rothberg B, Judson B, Morgensztern D. Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes. Journal Of Clinical Oncology 2013, 31: 6076-6076. DOI: 10.1200/jco.2013.31.15_suppl.6076.
• Role of adjuvant radiation in patients with squamous cell carcinomas of the oral cavity.Maron S, Gould Rothberg B, Otremba M, Judson B, Morgensztern D. Role of adjuvant radiation in patients with squamous cell carcinomas of the oral cavity. Journal Of Clinical Oncology 2013, 31: 6042-6042. DOI: 10.1200/jco.2013.31.15_suppl.6042.
• Parotid gland lymphoma: Prognostic analysis of 2140 patientsFeinstein AJ, Ciarleglio MM, Cong X, Otremba MD, Judson BL. Parotid gland lymphoma: Prognostic analysis of 2140 patients. The Laryngoscope 2013, 123: 1199-1203. PMID: 23576299, DOI: 10.1002/lary.23901.
• Maxillary swing approach for extended infratemporal fossa tumorsOtremba M, Adam S, Omay SB, Lowlicht R, Bulsara KR, Judson B. Maxillary swing approach for extended infratemporal fossa tumors. The Laryngoscope 2013, 123: 1607-1611. PMID: 23536535, DOI: 10.1002/lary.23947.
• Cervical dedifferentiated liposarcoma with meningothelial-like whorling.Blumberg JM, Jedrych J, Costa J, Judson B. Cervical dedifferentiated liposarcoma with meningothelial-like whorling. Head And Neck Pathology 2012, 6: 476-80. PMID: 22528826, PMCID: PMC3500890, DOI: 10.1007/s12105-012-0354-7.
• The Prognostic Importance of Midline Involvement in Oral Tongue CancerLloyd S, Yu JB, Wilson LD, Judson BL, Decker RH. The Prognostic Importance of Midline Involvement in Oral Tongue Cancer. American Journal Of Clinical Oncology 2012, 35: 468-473. PMID: 21701377, PMCID: PMC3755371, DOI: 10.1097/coc.0b013e3182195619.
• Role of excision repair cross‐complementation 1 expression as a prognostic marker for response to radiotherapy in early‐stage laryngeal cancerJohung K, Rewari A, Wu H, Judson B, Contessa JN, Haffty BG, Decker RH. Role of excision repair cross‐complementation 1 expression as a prognostic marker for response to radiotherapy in early‐stage laryngeal cancer. Head & Neck 2012, 35: 852-857. PMID: 22740347, PMCID: PMC5723082, DOI: 10.1002/hed.23041.
• Promoting Safe Swallowing When Puree is Swallowed Without Aspiration but Thin Liquid is Aspirated: Nectar is EnoughLeder SB, Judson BL, Sliwinski E, Madson L. Promoting Safe Swallowing When Puree is Swallowed Without Aspiration but Thin Liquid is Aspirated: Nectar is Enough. Dysphagia 2012, 28: 58-62. PMID: 22736260, DOI: 10.1007/s00455-012-9412-2.
• Influence of extracapsular extension on lymph node staging for patients with squamous cell carcinoma of the head and neck.Baumgart M, Acevedo-Gadea C, Wang Z, Buta E, Davies M, Deshpande H, Decker R, Sasaki C, Judson B, Herbst R, Morgensztern D. Influence of extracapsular extension on lymph node staging for patients with squamous cell carcinoma of the head and neck. Journal Of Clinical Oncology 2012, 30: 5532-5532. DOI: 10.1200/jco.2012.30.15_suppl.5532.
• Prognostic significance of the AJCC staging in patients with squamous cell carcinoma of the oropharynx.Acevedo-Gadea C, Baumgart M, Wang Z, Deshpande H, Davies M, Decker R, Sasaki C, Judson B, Herbst R, Morgensztern D. Prognostic significance of the AJCC staging in patients with squamous cell carcinoma of the oropharynx. Journal Of Clinical Oncology 2012, 30: 5529-5529. DOI: 10.1200/jco.2012.30.15_suppl.5529.
• Vagus Nerve Monitoring During Skull Base Surgery: A Transnasal Nerve Monitoring TechniqueSchutt C, Paskhover B, Judson B. Vagus Nerve Monitoring During Skull Base Surgery: A Transnasal Nerve Monitoring Technique. Journal Of Neurological Surgery Part B Skull Base 2012, 73 DOI: 10.1055/s-0032-1312093.
• Transcervical Double Mandibular Osteotomy Approach to the Infratemporal FossaAdam S, Bulsara K, Lowlicht R, Judson B. Transcervical Double Mandibular Osteotomy Approach to the Infratemporal Fossa. Journal Of Neurological Surgery Part B Skull Base 2012, 73 DOI: 10.1055/s-0032-1312275.
• Transcervical Double Mandibular Osteotomy Approach to the Infratemporal FossaJudson BL, Adam SI, Lowlicht R, Bulsara KR. Transcervical Double Mandibular Osteotomy Approach to the Infratemporal Fossa. World Neurosurgery 2011, 78: 715.e1-715.e5. PMID: 22381299, DOI: 10.1016/j.wneu.2011.12.015.
• Benign Inverted Papilloma with Intracranial Extension: Prognostic Factors and OutcomesWright EJ, Chernichenko N, Ocal E, Moliterno J, Bulsara KR, Judson BL. Benign Inverted Papilloma with Intracranial Extension: Prognostic Factors and Outcomes. Journal Of Neurological Surgery Reports 2011, 1: 145-150. PMID: 23984218, PMCID: PMC3743600, DOI: 10.1055/s-0031-1287687.
• Vocal Fold Immobility and Aspiration Status: A Direct Replication StudyLeder SB, Suiter DM, Duffey D, Judson BL. Vocal Fold Immobility and Aspiration Status: A Direct Replication Study. Dysphagia 2011, 27: 265-270. PMID: 21858715, DOI: 10.1007/s00455-011-9362-0.
• Inverted Papilloma with Intracranial ExtensionWright E, Chernichenko N, Moliterno J, Ocal E, Judson B, Bulsara K. Inverted Papilloma with Intracranial Extension. Journal Of Neurological Surgery Part B Skull Base 2011, 21 DOI: 10.1055/s-2011-1274355.
• UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression.Judson BL, Miyaki A, Kekatpure VD, Du B, Gilleaudeau P, Sullivan-Whalen M, Mohebati A, Nair S, Boyle JO, Granstein RD, Subbaramaiah K, Krueger JG, Dannenberg AJ. UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression. Cancer Prevention Research (Philadelphia, Pa.) 2010, 3: 1104-11. PMID: 20643784, PMCID: PMC2933319, DOI: 10.1158/1940-6207.CAPR-10-0089.
• Effects of cigarette smoke on the human oral mucosal transcriptome.Boyle JO, Gümüs ZH, Kacker A, Choksi VL, Bocker JM, Zhou XK, Yantiss RK, Hughes DB, Du B, Judson BL, Subbaramaiah K, Dannenberg AJ. Effects of cigarette smoke on the human oral mucosal transcriptome. Cancer Prevention Research (Philadelphia, Pa.) 2010, 3: 266-78. PMID: 20179299, PMCID: PMC2833216, DOI: 10.1158/1940-6207.CAPR-09-0192.
• UVR exposure sensitizes keratinocytes to DNA adduct formation.Nair S, Kekatpure VD, Judson BL, Rifkind AB, Granstein RD, Boyle JO, Subbaramaiah K, Guttenplan JB, Dannenberg AJ. UVR exposure sensitizes keratinocytes to DNA adduct formation. Cancer Prevention Research (Philadelphia, Pa.) 2009, 2: 895-902. PMID: 19789301, PMCID: PMC2758323, DOI: 10.1158/1940-6207.CAPR-09-0125.
• Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism.Judson BL, Shaha AR. Nuclear imaging and minimally invasive surgery in the management of hyperparathyroidism. Journal Of Nuclear Medicine : Official Publication, Society Of Nuclear Medicine 2008, 49: 1813-8. PMID: 18927330, PMCID: PMC3807731, DOI: 10.2967/jnumed.107.050237.
• Reconstructive application of the endotine suspension devices.Boehmler JH, Judson BL, Davison SP. Reconstructive application of the endotine suspension devices. Archives Of Facial Plastic Surgery 2007, 9: 328-32. PMID: 17875825, DOI: 10.1001/archfaci.9.5.328.